The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-Britain hits milestone as half of all adults get first vaccine dose

Sat, 20th Mar 2021 11:58

* Tally puts Britain ahead of major economies

* UK administered a record 660,276 shots on Friday

* Boris Johnson got AstraZeneca vaccine on Friday

* 26.9 mln given first dose out of 52.7 mln adult population
(Adds Health Minister comments, background)

By Sarah Young

LONDON, March 20 (Reuters) - Britain has hit a COVID-19
vaccination milestone with more than half of all adults having
had at least one injection, health secretary Matt Hancock said
on Saturday, making it the world's first major economy to
achieve that level of innoculation.

Britain's vaccine roll-out, which has raced ahead of those
in the European Union and the United States, means the country
is on track to ease lockdown measures and re-open the economy in
line with its plan, Hancock said.

"The vaccination programme is our route out of the
pandemic," Hancock told Sky News on Saturday. Official data
showed 26.9 million had received a first dose of vaccine, up
from 26.3 million the previous day.

Prime Minister Boris Johnson, who had AstraZeneca's
vaccine on Friday, tweeted "Let's keep going" after the
announcement that half of all adults had had a first shot.

Yet worries were also growing about a new wave of infections
in continental Europe as cases rise in countries including
Germany and France. A scientist who advises the government
warned on Saturday that holidays abroad were "extremely
unlikely" for most Britons this summer due to the risk of
importing new variants of COVID-19.

Asked if infection rates elsewhere in Europe concerned him,
Hancock said Britain had to stay vigilant but saw no threat to
plans to gradually re-open shops, pubs and restaurants from
April 12. "There is no sign that we won't be able to make
progress as set out in the roadmap," Hancock said.

Britain's vaccination roll-out, using the AstraZeneca and
Pfizer jabs, is one of the fastest in the world. Israel
tops the world in terms of the proportion of its population it
has vaccinated, followed by the United Arab Emirates, Chile,
then the UK.

By comparison, 23% of the U.S. population has received at
least one dose of a vaccine, and less than a 10th of the EU
population has been vaccinated.

ON TRACK FOR TARGETS

Britain's government has said it is aiming to give at least
one shot to everyone aged over 50 by mid-April and to every
adult by the end of July, targets which Hancock said would be
met.

Famous London landmarks like Westminister Abbey and the
Science Museum as well as local mosques and football stadiums
have hosted vaccine clinics.

The state-run health service also said that 2.1 million
people, or 4% of the population, have had a second dose and
almost 95% of people aged over 60 have been vaccinated.

The EU meanwhile is trying to get its vaccine programme back
on track after at least 13 countries temporarily suspended the
use of the AstraZeneca shot last week over safety concerns.

The European Medicines Agency has since said the benefits of
protecting people outweighed the possible risks from the
vaccine, but the damage to the AstraZeneca jab's reputation
could further slow the pace of the roll-out.

The struggle to secure vaccine supplies has left Britain and
the EU at loggerheads over vaccine exports. The EU threatened to
ban shipments to Britain on Wednesday.

Come April, Britain has warned its roll-out will slow due to
a supply crunch caused by a delayed shipment from India and the
need to retest one batch of vaccines.
(Reporting by Sarah Young
Editing by Andrew Heavens and David Holmes)

More News
Today 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.